Advertisement

Topics

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

04:49 EDT 16 Apr 2018 | Reuters

LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.

Original Article: Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

NEXT ARTICLE

More From BioPortfolio on "Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...